Akinesia: Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 5: | Line 5: | ||
'''Akinesia''' (from the prefix ''a-'', "without", and the Greek κίνηση, ''kinisi'', "motion") is the inability to initiate movement due to difficulty selecting and/or activating motor programs in the central nervous system. Common in severe cases of [[Parkinson's disease]], akinesia is a result of severely diminished [[dopamine|dopaminergic]] cell activity in the [[direct pathway of movement]]. | '''Akinesia''' (from the prefix ''a-'', "without", and the Greek κίνηση, ''kinisi'', "motion") is the inability to initiate movement due to difficulty selecting and/or activating motor programs in the central nervous system. Common in severe cases of [[Parkinson's disease]], akinesia is a result of severely diminished [[dopamine|dopaminergic]] cell activity in the [[direct pathway of movement]]. | ||
===Drug Side Effect=== | |||
*[[Loxapine]] | |||
== Akinetic Mutism == | == Akinetic Mutism == | ||
Revision as of 20:54, 26 January 2015
|
WikiDoc Resources for Akinesia |
|
Articles |
|---|
|
Most recent articles on Akinesia |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Akinesia at Clinical Trials.gov Clinical Trials on Akinesia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Akinesia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Akinesia Risk calculators and risk factors for Akinesia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Akinesia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Akinesia (from the prefix a-, "without", and the Greek κίνηση, kinisi, "motion") is the inability to initiate movement due to difficulty selecting and/or activating motor programs in the central nervous system. Common in severe cases of Parkinson's disease, akinesia is a result of severely diminished dopaminergic cell activity in the direct pathway of movement.
Drug Side Effect
Akinetic Mutism
Akinetic mutism is a condition in which a person is both mute and akinetic. A textbook on clinical neurology observes that a person with akinetic mutism has "sleep-waking cycles but, when apparently awake, with eyes open, lies mute, immobile and unresponsive." Some dictionaries describe it as "loss of normal muscle tone."